|
Efficacy and safety of daratumumab, lenalidomide, and dexamethasone (D-Rd) in relapsed or refractory multiple myeloma (RRMM): Updated subgroup analysis of POLLUX based on cytogenetic risk. |
|
|
|
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celgene; Incyte; Janssen; Karyopharm Therapeutics; Pharmacyclics; Roche; Takeda; TG Therapeutics |
Research Funding - Celgene (Inst); Merck (Inst); Novartis (Inst) |
|
|
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Takeda |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Takeda |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Research Funding - Abbvie; Celgene; La Jolla Pharma; Novartis; Pi Square LLC; Takeda |
|
|
Consulting or Advisory Role - Amgen; Celgene; Janssen; Takeda |
|
|
Honoraria - Amgen; Celgene; Janssen-Cilag; Novartis; Takeda |
Consulting or Advisory Role - Amgen; Celgene; Janssen; Novartis; Takeda |
|
|
Honoraria - Amgen; Celgene; Janssen |
Consulting or Advisory Role - Amgen; Celgene; Janssen |
Research Funding - GlaxoSmithKline; Janssen; Karyopharm Therapeutics |
|
|
Honoraria - Bristol-Myers Squibb; Celgene; Janssen; Ono Pharmaceutical; Takeda |
Research Funding - Bristol-Myers Squibb; Chugai Pharma; Kyowa Hakko Kirin; Ono Pharmaceutical |
|
|
No Relationships to Disclose |
|
|
Honoraria - Amgen; Celgene; Janssen; Takeda |
Consulting or Advisory Role - Amgen; Celgene; Janssen; Takeda |
Research Funding - Allergan |
Travel, Accommodations, Expenses - Amgen; Janssen |
|
|
Consulting or Advisory Role - Amgen; Celgene; Janssen; Takeda |
Speakers' Bureau - Amgen; Celgene |
|
|
Honoraria - Abbvie; Amgen; Celgene; Janssen |
Consulting or Advisory Role - Abbvie; Celgene; Janssen |
Research Funding - Celgene |
Travel, Accommodations, Expenses - Celgene; Janssen |
|
|
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Array Biopharma; Bayer; Celgene; Janssen Oncology; Millennium; Novartis; Seagen |
Research Funding - Acetylon Pharmaceuticals (Inst); Array BioPharma; Biotest (Inst); Bristol-Myers Squibb (Inst); Celgene; Janssen; Millennium; Novartis; Onyx; Pharmacyclics |
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Janssen Oncology; Novartis; Takeda |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - Johnson & Johnson |
|
|
|
Stock and Other Ownership Interests - Janssen |
|
|
|
Stock and Other Ownership Interests - Janssen |
|
|
|
Stock and Other Ownership Interests - Janssen |
|
|
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; MSD; Novartis; Roche; Sanofi; Takeda |